ENRASENTAN



ENRASENTAN


SMILES CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2
InChIKey GLCKXJLCYIJMRB-UPRLRBBYSA-N

Chemical Properties

Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 10
Molecular weight (Da) 506.2

Database connections



No bioactivity data available.

ENRASENTAN


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Clinical Trials

Phase I 0
Phase II 0
Phase III 0
Approved No

Database connections



Compound is not listed as a drug.